TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
55.70
+0.30 (0.54%)
Jan 22, 2026, 1:30 PM CST

TSH Biopharm Corporation Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
125.02113.0961.9961.8947.1161.57
Upgrade
Depreciation & Amortization
19.3127.5621.3420.619.659.54
Upgrade
Other Amortization
7.851.41.230.910.140.11
Upgrade
Loss (Gain) From Sale of Assets
-0.440.870.040.060-
Upgrade
Asset Writedown & Restructuring Costs
8.88.8--4.154.58
Upgrade
Loss (Gain) From Sale of Investments
-----1.56
Upgrade
Provision & Write-off of Bad Debts
0.30.76-1.933.04-0.1-0.1
Upgrade
Other Operating Activities
25.5135.14-8.83-1.3-15.640.95
Upgrade
Change in Accounts Receivable
-27.6448.61-5.52-10.419.055.14
Upgrade
Change in Inventory
-19.85-44.91-11.01-13.954.69-18.85
Upgrade
Change in Accounts Payable
31.05-43.14-5.93-49.466.33-34.66
Upgrade
Change in Unearned Revenue
-1.56-0.8-3.595.23--2.48
Upgrade
Change in Other Net Operating Assets
7.7436.4-13.9317.743.34-15.74
Upgrade
Operating Cash Flow
176.08183.7733.8734.3568.7111.61
Upgrade
Operating Cash Flow Growth
40.80%442.54%-1.40%-50.00%491.74%-86.90%
Upgrade
Capital Expenditures
-4.18-1.73-5.38-3.73-0.38-1.92
Upgrade
Sale of Property, Plant & Equipment
0.050.3-0.03--
Upgrade
Cash Acquisitions
--242.87----
Upgrade
Sale (Purchase) of Intangibles
-6.17-1.02-0.18-15--0.46
Upgrade
Investment in Securities
-77.39127.94167.8744.67-14.28229.43
Upgrade
Other Investing Activities
7.646.99-1.297.424.67.16
Upgrade
Investing Cash Flow
-78.59-110.38161.0233.4-10.06234.21
Upgrade
Short-Term Debt Issued
---20--
Upgrade
Long-Term Debt Issued
---30--
Upgrade
Total Debt Issued
---50--
Upgrade
Short-Term Debt Repaid
---20-61.07--
Upgrade
Long-Term Debt Repaid
--12.54-35.73-20.93-4.35-4.22
Upgrade
Total Debt Repaid
-12.53-12.54-55.73-82-4.35-4.22
Upgrade
Net Debt Issued (Repaid)
-12.53-12.54-55.73-32-4.35-4.22
Upgrade
Common Dividends Paid
-81.4-49.15-61.44-57.6-69.12-69.12
Upgrade
Other Financing Activities
--9.990.2--
Upgrade
Financing Cash Flow
-93.94-61.69-107.18-89.4-73.46-73.33
Upgrade
Foreign Exchange Rate Adjustments
-0.010.06-0.030.03--
Upgrade
Net Cash Flow
3.5411.7687.68-21.62-14.81172.49
Upgrade
Free Cash Flow
171.9182.0428.4930.6268.339.7
Upgrade
Free Cash Flow Growth
39.68%538.93%-6.96%-55.18%604.75%-88.68%
Upgrade
Free Cash Flow Margin
13.53%16.32%3.51%4.13%16.52%2.17%
Upgrade
Free Cash Flow Per Share
4.474.740.740.801.780.25
Upgrade
Cash Interest Paid
0.740.460.690.70.080.03
Upgrade
Cash Income Tax Paid
51.1519.2415.913.9823.748.29
Upgrade
Levered Free Cash Flow
177.59138.948.75-18.8562.7-1.52
Upgrade
Unlevered Free Cash Flow
178.05139.239.18-18.4162.75-1.5
Upgrade
Change in Working Capital
-10.26-3.84-39.97-50.8623.41-66.6
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.